Table of Contents Author Guidelines Submit a Manuscript
Cardiology Research and Practice
Volume 2010, Article ID 856418, 9 pages
http://dx.doi.org/10.4061/2010/856418
Research Article

Gadolinium Enhanced MR Coronary Vessel Wall Imaging at 3.0 Tesla

1Department of Medicine/Cardiology, Deutsches Herzzentrum Berlin, Augustenburger Platz 1, 13353 Berlin, Germany
2Division of Magnetic Resonance Research, Department of Radiology, Johns Hopkins University, School of Medicine, 601 North Caroline Street, Baltimore, MD 21287, USA
3Division of Cardiology, Department of Medicine, Johns Hopkins University, Baltimore, MD 21205-2196, USA
4Department of Electrical and Computer Engineering, Johns Hopkins University, Baltimore, MD 21205-2196, USA

Received 6 April 2010; Revised 12 July 2010; Accepted 16 September 2010

Academic Editor: Vicky A. Cameron

Copyright © 2010 Sebastian Kelle et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. Maintz, M. Ozgun, A. Hoffmeier et al., “Selective coronary artery plaque visualization and differentiation by contrast-enhanced inversion prepared MRI,” European Heart Journal, vol. 27, no. 14, pp. 1732–1736, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. D. B. Weinreb, J. G. S. Aguinaldo, J. E. Feig, E. A. Fisher, and Z. A. Fayad, “Non-invasive MRI of mouse models of atherosclerosis,” NMR in Biomedicine, vol. 20, no. 3, pp. 256–264, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. C. M. Kramer, L. A. Cerilli, K. Hagspiel, J. M. DiMaria, F. H. Epstein, and J. A. Kern, “Magnetic resonance imaging identifies the fibrous cap in atherosclerotic abdominal aortic aneurysm,” Circulation, vol. 109, no. 8, pp. 1016–1021, 2004. View at Publisher · View at Google Scholar · View at Scopus
  4. T. Saam, T. S. Hatsukami, N. Takaya et al., “The vulnerable, or high-risk, atherosclerotic plaque: noninvasive MR imaging for characterization and assessment,” Radiology, vol. 244, no. 1, pp. 64–77, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. R. M. Botnar, M. Stuber, K. V. Kissinger, W. Y. Kim, E. Spuentrup, and W. J. Manning, “Noninvasive coronary vessel wall and plaque imaging with magnetic resonance imaging,” Circulation, vol. 102, no. 21, pp. 2582–2587, 2000. View at Google Scholar · View at Scopus
  6. W. Y. Kim, M. Stuber, P. Börnert, K. V. Kissinger, W. J. Manning, and R. M. Botnar, “Three-dimensional black-blood cardiac magnetic resonance coronary vessel wall imaging detects positive arterial remodeling in patients with nonsignificant coronary artery disease,” Circulation, vol. 106, no. 3, pp. 296–299, 2002. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Y. Desai, J. H. Stone, T. K. F. Foo, D. B. Hellmann, J. A. C. Lima, and D. A. Bluemke, “Delayed contrast-enhanced MRI of the aortic wall in Takayasu's arteritis: initial experience,” American Journal of Roentgenology, vol. 184, no. 5, pp. 1427–1431, 2005. View at Google Scholar · View at Scopus
  8. C. Yuan, W. S. Kerwin, M. S. Ferguson et al., “Contrast-enhanced high resolution MRI for atherosclerotic carotid artery tissue characterization,” Journal of Magnetic Resonance Imaging, vol. 15, no. 1, pp. 62–67, 2002. View at Publisher · View at Google Scholar · View at Scopus
  9. J. Cai, T. S. Hatsukami, M. S. Ferguson et al., “In vivo quantitative measurement of intact fibrous cap and lipid-rich necrotic core size in atherosclerotic carotid plaque: comparison of high-resolution, contrast-enhanced magnetic resonance imaging and histology,” Circulation, vol. 112, no. 22, pp. 3437–3444, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. B. A. Wasserman, W. I. Smith, H. H. Trout III, R. O. Cannon III, R. S. Balaban, and A. E. Arai, “Carotid artery atherosclerosis: in vivo morphologic characterization with gadolinium-enhanced double-oblique MR imaging—initial results,” Radiology, vol. 223, no. 2, pp. 566–573, 2002. View at Google Scholar
  11. T. Ibrahim, J. Dirschinger, S. Schachoff et al., “Darstellung der Koronargefaesswand mittels kontrastunterstuetzter Magnet-Resonanz-Tomographie bei Patienten mit koronarer Herzerkrankung,” Clinical Research in Cardiology, vol. 95, supplement 5, abstract KN864, 2006. View at Google Scholar
  12. R. Wessely, R. M. Botnar, M. Vorpahl, M. Schwaiger, A. Schömig, and T. Ibrahim, “Images in cardiovascular medicine. Subacute thrombotic occlusion and spontaneous recanalization of the right coronary artery after percutaneous coronary intervention for ST-elevation myocardial infarction visualized by coronary angiography and cardiac magnetic resonance imaging,” Circulation, vol. 116, no. 3, pp. e78–e80, 2007. View at Publisher · View at Google Scholar
  13. S. B. Yeon, A. Sabir, M. Clouse et al., “Delayed-enhancement cardiovascular magnetic resonance coronary artery wall imaging. Comparison with multislice computed tomography and quantitative coronary angiography,” Journal of the American College of Cardiology, vol. 50, no. 5, pp. 441–447, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. S. E. Fischer, S. A. Wickline, and C. H. Lorenz, “Novel real-time R-wave detection algorithm based on the vectorcardiogram for accurate gated magnetic resonance acquisitions,” Magnetic Resonance in Medicine, vol. 42, no. 2, pp. 361–370, 1999. View at Publisher · View at Google Scholar · View at Scopus
  15. R. Nezafat, M. Stuber, R. Ouwerkerk, A. M. Gharib, M. Y. Desai, and R. I. Pettigrew, “B1-insensitive T2 preparation for improved coronary magnetic resonance angiography at 3 T,” Magnetic Resonance in Medicine, vol. 55, no. 4, pp. 858–864, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. A. Etienne, R. M. Botnar, A. M. C. Van Muiswinkel, P. Boesiger, W. J. Manning, and M. Stuber, “"Soap-Bubble" visualization and quantitative analysis of 3D coronary magnetic resonance angiograms,” Magnetic Resonance in Medicine, vol. 48, no. 4, pp. 658–666, 2002. View at Publisher · View at Google Scholar · View at Scopus
  17. P. J. Scanlon, D. P. Faxon, A. -M. Audet et al., “ACC/AHA Guidelines for Coronary Angiography. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Coronary Angiography). Developed in collaboration with the Society for Cardiac Angiography and Interventions,” Journal of the American College of Cardiology, vol. 33, no. 6, pp. 1756–1824, 1999. View at Publisher · View at Google Scholar
  18. X. Bi, V. Deshpande, O. Simonetti, G. Laub, and D. Li, “Three-dimensional breathhold SSFP coronary MRA: a comparison between 1.5T and 3.0T,” Journal of Magnetic Resonance Imaging, vol. 22, no. 2, pp. 206–212, 2005. View at Publisher · View at Google Scholar · View at Scopus
  19. X. Bi, J. C. Carr, and D. Li, “Whole-heart coronary magnetic resonance angiography at 3 Tesla in 5 minutes with slow infusion of Gd-BOPTA, a high-relaxivity clinical contrast agent,” Magnetic Resonance in Medicine, vol. 58, no. 1, pp. 1–7, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Stuber, P. Börnert, E. Spuentrup, R. M. Botnar, and W. J. Manning, “Selective three-dimensional visualization of the coronary arterial lumen using arterial spin tagging,” Magnetic Resonance in Medicine, vol. 47, no. 2, pp. 322–329, 2002. View at Publisher · View at Google Scholar · View at Scopus
  21. J. Pintaske, P. Martirosian, H. Graf et al., “Relaxivity of gadopentetate dimeglumine (Magnevist), gadobutrol (Gadovist), and gadobenate dimeglumine (MultiHance) in human blood plasma at 0.2, 1.5, and 3 Tesla,” Investigative Radiology, vol. 41, no. 3, pp. 213–221, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. S. Kelle, T. Kokocinski, T. Thouet et al., “1.5 vs. 3.0 Tesla—reduction of contrast agent dosage for scar-imaging possible?” European Heart Journal, vol. 27, pp. 422–423, 2005. View at Google Scholar
  23. B. Klumpp, M. Fenchel, T. Hoevelborn et al., “Assessment of myocardial viability using delayed enhancement magnetic resonance imaging at 3.0 Tesla,” Investigative Radiology, vol. 41, no. 9, pp. 661–667, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. P. Marckmann, L. Skov, K. Rossen et al., “Nephrogenic systemic fibrosis: suspected causative role of gadodiamide used for contrast-enhanced magnetic resonance imaging,” Journal of the American Society of Nephrology, vol. 17, no. 9, pp. 2359–2362, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. R. J. Kim, D. J. Shah, and R. M. Judd, “How we perform delayed enhancement imaging,” Journal of Cardiovascular Magnetic Resonance, vol. 5, no. 3, pp. 505–514, 2003. View at Publisher · View at Google Scholar · View at Scopus
  26. D. C. Look and D. R. Locker, “Time saving in measurement of NMR and EPR relaxation times,” Review of Scientific Instruments, vol. 41, no. 2, pp. 250–251, 1970. View at Publisher · View at Google Scholar · View at Scopus